CorMedix (CRMD)

• Market cap: $987M
• 1 day: 2.79%
• 5 days: 5.65%
• 1 month: 29.84%
• 3 months: 10.88%
• 6 months: -16.24%
• Year to date: 52.43%
• 1 year: 47.41%
• 5 years: 68.19%
• 10 years: 22.24%
• Sector: Healthcare
• Industry: Biotechnology

About: Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Employees: 82